Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Magnetic Stimulation in Laryngeal Dystonia

NCT: NCT07683767 · NOT_YET_RECRUITING

NCT IDNCT07683767
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2027-02
SponsorUniversidade Federal de Pernambuco (OTHER)
First posted
Last updated

Brief Summary

This randomized clinical trial with a crossover design aims to investigate the effects of neuromodulation through repetitive transcranial magnetic stimulation (rTMS) applied to patients diagnosed with laryngeal dystonia. Participants will undergo three experimental conditions: (1) rTMS alone, (2) rTMS combined with speech-language therapy, and (3) sham rTMS combined with speech-language therapy. The order of the conditions will be randomized. Each phase of the protocol will consist of five consecutive sessions. Outcomes will include acoustic vocal quality parameters, perceptual-auditory voice assessment, self-ratings of vocal effort, smoothed cepstral peak prominence measures, and global perceived change following the intervention. It is expected that the study will contribute to a better understanding of the effects of the intervention on vocal outcomes, supporting the optimization and standardization of therapeutic protocols for laryngeal dystonia.

Frequently Asked Questions

What is Transcranial Magnetic Stimulation in Laryngeal Dystonia?

Transcranial Magnetic Stimulation in Laryngeal Dystonia is a clinical trial registered under NCT07683767. Current status: NOT_YET_RECRUITING.

What is the status of NCT07683767?

The current status of NCT07683767 (Transcranial Magnetic Stimulation in Laryngeal Dystonia) is: NOT_YET_RECRUITING.

When did Transcranial Magnetic Stimulation in Laryngeal Dystonia start?

Transcranial Magnetic Stimulation in Laryngeal Dystonia started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.